Regeneron Targets Vulnerable Populations In COVID-19 Pact With BARDA

Regeneron is partnering with BARDA to develop a next-generation COVID-19 antibody • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from COVID-19

More from Scrip